Houston, TXNCT06959706Now EnrollingIRB Ready

Advanced Solid Tumors Clinical Trial in Houston, TX

Access cutting-edge advanced solid tumors treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by Tagworks Pharmaceuticals BV

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access advanced solid tumors specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related advanced solid tumors treatment provided free

Apply for This Houston Location

Check if you qualify for this advanced solid tumors clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This Advanced Solid Tumors Study in Houston

The primary objectives of this study are to evaluate the safety and tolerability of TGW101 and determine the recommended dosing regimen(s) for further study. The secondary objectives are to assess pharmacokinetics and preliminary antitumor activity.

Sponsor: Tagworks Pharmaceuticals BV

Who Can Participate

Inclusion Criteria

Written informed consent prior to any study procedures.
Males or females 18 years or older.
Histologically or cytologically confirmed diagnosis of a solid tumor malignancy listed below, with radiographic evidence of disease progression based on Response Evaluation Criteria in Solid Tumors (RECIST v1.1), or for castration resistant prostate cancer (CRPC), Prostate Cancer Clinical Trials Working Group 3, after most recent treatment and locally advanced or metastatic disease at Screening:
Breast cancer (all subtypes).
Castrate-resistant prostate cancer.
Cervical cancer.
Endometrial cancer.
Esophageal, adenocarcinoma only.
Gastric/gastroesophageal junction (GEJ).
Non-squamous cell carcinoma of the head and neck, e.g., salivary gland neoplasms, with the exception of adenoid cystic carcinoma.
Non-small cell lung cancer, adenocarcinoma only.
Refractory disease, intolerance to, or documented refusal of available standard therapy(ies) known to provide clinical benefit for the participant's solid tumor malignancy per Investigator judgment.
At least 1 measurable lesion per RECIST v1.1 except for participants with bone-only metastatic disease.
Biopsy pretreatment; if not possible, archival tissue block (preferred) or unstained formalin-fixed paraffin-embedded slides required.
Eastern Cooperative Oncology Group Performance Status 0-1.
Life expectancy of \> 3 months in the opinion of the Investigator.
Adequate hepatic, hematologic, and renal function.

Exclusion Criteria

Active second malignancy or history of another malignancy within the last 2 years, with the exception of: treated non-melanoma skin cancers; treated carcinoma in situ (e.g., breast and cervix); controlled superficial carcinoma of the urinary bladder; T1a or b carcinoma of the prostate; papillary thyroid carcinoma Stage I treated surgically for cure.
Known symptomatic brain metastases.
Significant cardiovascular disease within 6 months prior to starting study drug.
Evidence of an active systemic bacterial, fungal, or viral infection requiring treatment.
Grade ≥ 2 peripheral neuropathy.
Major surgery within 4 weeks prior to starting study drug.
Prior solid organ or bone marrow progenitor cell transplantation.
Prior high-dose chemotherapy requiring stem cell rescue.
Anticancer therapy within 28 days or within 5 half-lives (whichever is shorter) prior to starting study drug.
Palliative radiation therapy within 14 days prior to starting study drug.
Live vaccine within 28 days prior to starting study drug.
Pregnant or a breastfeeding postpartum female.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT06959706) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Advanced Solid Tumors Treatment Options in Houston, TX

If you're searching for advanced solid tumors treatment options in Houston, TX, this clinical trial (NCT06959706) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all advanced solid tumors clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in Houston, TX

See all advanced solid tumors clinical trials recruiting in Houston — not just this study.

Browse Advanced Solid Tumors Trials in Houston →

Browse More Trials by Condition

Advanced Solid Tumors TrialsAlzheimers Disease TrialsAtopic Dermatitis TrialsErectile Dysfunction TrialsAll Conditions →

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX